404 related articles for article (PubMed ID: 37436725)
1. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
2. Patient Experiences and Provider Perspectives on Accessing Gender-Affirming Surgical Services in the Veterans Health Administration.
Boyer TL; Wolfe HL; Littman AJ; Shipherd JC; Kauth MR; Blosnich JR
J Gen Intern Med; 2023 Dec; 38(16):3549-3557. PubMed ID: 37670068
[TBL] [Abstract][Full Text] [Related]
3. Exploring Research Engagement and Priorities of Transgender and Gender Diverse Veterans.
Wolfe HL; Boyer TL; Rodriguez KL; Klima GJ; Shipherd JC; Kauth MR; Blosnich JR
Mil Med; 2023 May; 188(5-6):e1224-e1231. PubMed ID: 34791410
[TBL] [Abstract][Full Text] [Related]
4. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
5. Implementation of LGBTQ+ affirming care policies in the Veterans Health Administration: preliminary findings on barriers and facilitators in the southern United States.
Singh RS; Landes SJ; Willging CE; Abraham TH; McFrederick P; Kauth MR; Shipherd JC; Kirchner JE
Front Public Health; 2023; 11():1251565. PubMed ID: 38352130
[TBL] [Abstract][Full Text] [Related]
6. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
7. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
8. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of a transgender and gender-diverse patient population in Utah: Use of electronic health records to advance clinical and health equity research.
Ho TF; Zenger B; Mark B; Hiatt L; Sullivan E; Steinberg BA; Lyons A; Spivak AM; Agarwal C; Adelman M; Hotaling J; Kiraly B; Talboys S
PLoS One; 2024; 19(5):e0302895. PubMed ID: 38713697
[TBL] [Abstract][Full Text] [Related]
10. HIV prevention and HIV care among transgender and gender diverse youth: design and implementation of a multisite mixed-methods study protocol in the U.S.
Jadwin-Cakmak L; Reisner SL; Hughto JMW; Salomon L; Martinez M; Popoff E; Rivera BA; Harper GW
BMC Public Health; 2019 Nov; 19(1):1531. PubMed ID: 31730450
[TBL] [Abstract][Full Text] [Related]
11. Barriers Pediatric PCP's Identify To Providing Gender-Affirming Care For Adolescents.
Sequeira GM; Kahn NF; Ricklefs C; Collin A; Asante PG; Pratt W; Christakis D; Richardson LP
J Adolesc Health; 2023 Aug; 73(2):367-374. PubMed ID: 37294258
[TBL] [Abstract][Full Text] [Related]
12. Reproductive health risks and clinician practices with gender diverse adolescents and young adults.
Quinn GP; Tishelman AC; Chen D; Nahata L
Andrology; 2021 Nov; 9(6):1689-1697. PubMed ID: 33942552
[TBL] [Abstract][Full Text] [Related]
13. Decreased Anogenital Gonorrhea and Chlamydia in Transgender and Gender Diverse Primary Care Patients Receiving Gender-Affirming Hormone Therapy.
Reisner SL; Deutsch MB; Mayer KH; Pletta DR; Campbell J; Potter J; Keuroghlian AS; Hughto JMW; Asquith A; Pardee DJ; Harris A; Quint M; Grasso C; Gonzalez A; Radix A
J Gen Intern Med; 2024 May; 39(7):1164-1172. PubMed ID: 37989820
[TBL] [Abstract][Full Text] [Related]
14. Transgender and gender diverse veterans' access to gender-related health care services: The role of minority stress.
Powell HA; Stinson RD; Erbes C
Psychol Serv; 2022 Aug; 19(3):455-462. PubMed ID: 34043382
[TBL] [Abstract][Full Text] [Related]
15. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.
Iwamoto SJ; Grimstad F; Irwig MS; Rothman MS
J Gen Intern Med; 2021 May; 36(5):1380-1389. PubMed ID: 33547576
[TBL] [Abstract][Full Text] [Related]
16. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
17. Patient Characteristics Associated with Receiving Gender-Affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Vimalananda VG; Wong DH; Reisman JI; Rao SR; Shipherd JC; Blosnich JR; Livingston NA; Jasuja GK
Transgend Health; 2024 Apr; 9(2):151-161. PubMed ID: 38694620
[TBL] [Abstract][Full Text] [Related]
18. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
